athymic nuide mice, the response to DTIC (Dacarbazine, NSC-45388), CCNU (Lomustine, NSC-79037) and procarbazine was in fact inversely related to the growth rate of the xenografts.
In a recent study of 6 human melanomas, serially transplanted into nude mice (BALB/c background) the early growth rate measured in the range 30-60 mm3 was found to be a characteristic and constant property of the xenografts (Fodstad et al., 1 980a ). The growth rates of the individual tumours varied by more than 3-fold. This opened the possibility of studying the relationship between the growth rate of the xenografts and their chemosensitivity. We report here on the effect of DTIC, CCNU and procarbazine, 3 of the most effective drugs in the treatment of human melanomas (Luce, 1972; Comis, 1976 Courtenay & Mills (1978) . For each drug the different tumours showed the same relative sensitivity in vitro as found here in vivo (Tveit et al., submitted) . An inverse relationship between growth rate of the melanoma xenografts and their chemosensitivity was not found for some other drugs tested. In experiments reported elsewhere (Fodstad et al., 1980b) we studied the effect of the toxic lectins abrin and ricin that have been found to be as effective against various human xenografts as some established cytostatic drugs (Fodstad et al., 1977; Pihl et al., 1979) . We also tested vinblastine which has been reported to give a response in about 15% of human melanomas (Comis, 1976) . With these 3 agents a clear response was obtained in most of the xenografts. However, in these instances the response of the different xenografts showed no relationship to their growth rates.
DTIC and CCNU are known to have a stronger effect on proliferating than on resting marrow cells (Valeriote & van Putten, 1975) . On this basis, it might be anticipated that their effect would be positively correlated with the growth rate of the tumours. The inverse relationship here found was therefore highly unexpected.
The underlying mechanism of the data here observed can only be revealed by detailed kinetic studies. Whatever the mechanism, our data show that the relationship between growth rate and chemosensitivity may be more complicated than hitherto assumed. If further data corroborate the evidence now available that the chemosensitivity of human xenografts reflects that of the tumours in situ Povlsen, 1978; Osieka et al., 1977) the present results open the possibility that measurements of growth parameters of the parent melanomas may be of aid to clinicians in predicting the response to at least some chemotherapeutic agents.
